Funding for this research was provided by:
NIH-funded CCASAnet (U01AI069923, K24 AI065298)
Received: 21 September 2021
Accepted: 28 March 2022
First Online: 5 April 2022
: Institutional review board approval was obtained locally for each participating site for the constitution of the CCASAnet cohort, and data are coordinated by the Vanderbilt University Medical Center, Nashville, TN, USA. At each of the sites contributing data for this study, except the participant site in Peru (Instituto de Medicina Tropical Alexander von Humboldt, IMTAvH); the Ethic Committee of Instituto Nacional de Infectologia Evandro Chagas, in Brazil; the Ethic Committee of Fundación Arriarán, in Chile; the Ethic Committee of Le Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO), in Haiti; the Ethic Commitee of Hospital Escuela and Instituto Hondureño de Seguridad Social, in Honduras; and the Ethic Committee of Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, in Mexico permit retrospective analysis of de-identified clinical data without informed consent.
: Not applicable.
: The authors declare that they have no competing interests.